Salomon & Ludwin’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.39K Hold
335
– – ﹤0.01% 1368
2026
Q2
$8.38K Hold
335
– – ﹤0.01% 1660
2026
Q1
$7.6K Buy
335
+89
+36% +$1.98K ﹤0.01% 1625
2025
Q4
$6.18K Sell
246
-88
-26% -$2.09K ﹤0.01% 1699
2025
Q3
$8.3K Buy
+334
New +$8.2K ﹤0.01% 1448

Other funds holding PCRX

Salomon & Ludwin's PCRX Position: Q3 2026 in Review

Salomon & Ludwin held its Pacira BioSciences (PCRX) position steady in Q3 2026 at 335 shares worth $8.39K. The position accounts for ﹤0.01% of the portfolio, ranked #1368.

Salomon & Ludwin first reported a position in PCRX in Q3 2025 and has held it in 5 quarters since. 258 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.

  • Salomon & Ludwin held 335 shares of Pacira BioSciences worth $8.39K as of Q3 2026.
  • Salomon & Ludwin left its Pacira BioSciences share count unchanged in Q3 2026.
  • Pacira BioSciences made up ﹤0.01% of Salomon & Ludwin's portfolio in Q3 2026, its #1368 holding.
  • Salomon & Ludwin first reported a position in Pacira BioSciences in Q3 2025 and has held it in 5 quarters since.
  • 258 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.

Based on Salomon & Ludwin's 13F filing for Q3 2026, filed 29 Oct 2026.